pharmaceuticals

Global Custom Market Research Reports Provider Company

phone

Asarina Pharma AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 19
  • Category: Pharmaceuticals
  • Country: Sweden
Summary

Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB is a drug development company that concentrates on the discovery, development and commercialization of novel treatments for women suffering from premenstrual dysphoric disorder and other menstrual cycle linked conditions. The companys lead product candidate includes sepranolone, an endogenous, compound and a GABA-A modulating steroid antagonist. Its sepranolone is a non-hormonally active compound that inhibits the disease provoking effect of the progesterone metabolite in women suffering from PMDD. The company has presence in Sweden and Denmark. Asarina Pharma is headquartered in Solna, Sweden.

Asarina Pharma AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Asarina Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Asarina Pharma AB, Medical Devices Deals, 2012 to YTD 2018 9
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Asarina Pharma Raises USD7.7 Million in Venture Financing 11
Partnerships 12
Ergomed Enters into Co-Development Agreement with Asarina Pharma 12
Acquisition 13
BrainsToVentures And Rosetta Capital Acquire Minority Stake In 13 Portfolio Companies Of Karolinska Development For US$34 Million 13
Asarina Pharma AB - Key Competitors 16
Asarina Pharma AB - Key Employees 17
Asarina Pharma AB - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List Of Tables

List of Tables
Asarina Pharma AB, Pharmaceuticals & Healthcare, Key Facts 2
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Asarina Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Asarina Pharma AB, Deals By Therapy Area, 2012 to YTD 2018 8
Asarina Pharma AB, Medical Devices Deals, 2012 to YTD 2018 9
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Asarina Pharma Raises USD7.7 Million in Venture Financing 11
Ergomed Enters into Co-Development Agreement with Asarina Pharma 12
BrainsToVentures And Rosetta Capital Acquire Minority Stake In 13 Portfolio Companies Of Karolinska Development For US$34 Million 13
Asarina Pharma AB, Key Competitors 16
Asarina Pharma AB, Key Employees 17
Asarina Pharma AB, Subsidiaries 18

List Of Figures

List of Figures
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Asarina Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Asarina Pharma AB, Medical Devices Deals, 2012 to YTD 2018 9

Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB is a drug development company that concentrates on the discovery, development and commercialization of novel treatments

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports